Arthur Riggs serves as Executive at LIXTE BIOTECHNOLOGY HOLDINGS, INC., where they oversee executive responsibilities. Since joining the company, Arthur Riggs has executed 1 insider transactions totaling $630.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 7, 2018 involved purchasing 1,260,000 shares valued at $630.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 7, 2018 | LIXT.OB | $630.0K | Purchase | 1,260,000 | $0.50 | Discretionary |
Arthur Riggs currently holds 6,110,000 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arthur Riggs has been a net buyer of LIXT.OB stock. They have purchased $630.0K and sold $0 worth of shares.
Arthur Riggs's most recent insider trade was on Dec 7, 2018, when they purchased 1,260,000 shares at $0.50 per share.
Get notified when new Form 4 filings are submitted